<DOC>
	<DOCNO>NCT02905890</DOCNO>
	<brief_summary>The propose study , Hormonal Contraception &amp; BV ( HCBV ) , investigate effect NET-EN DMPA recurrent BV , vaginal microbiota inflammatory marker among woman high risk HIV Kampala , Uganda . The hypothesis NET-EN show similar beneficial effect recurrent BV vaginal microbiota DMPA , without induce sign mucosal inflammation .</brief_summary>
	<brief_title>The Effect Norethisterone Enanthate Recurrent Bacterial Vaginosis</brief_title>
	<detailed_description>Bacterial vaginosis ( BV ) highly prevalent among woman Africa associate HIV acquisition . BV describe dysbiosis , microbial imbalance , treated metronidazole ; however , treat , often recur rapidly . Developing robust treatment strategy prevent recurrent BV important HIV prevention key population high risk HIV infection . There evidence hormonal contraceptive , include depot medroxyprogesterone acetate ( DMPA ) , decrease BV recurrence ; however , also evidence DMPA increase risk HIV infection . Encouraging woman start switch alternative progestin injectable norethisterone enantate ( NET-EN ) may mitigate HIV risk whilst decrease risk recurrent BV . To date , publish study investigated effect NET-EN vaginal microbiota . The propose study investigate effect NET-EN DMPA recurrent BV , vaginal microbiota inflammatory marker among woman high risk HIV Good Health Women Project Kampala , Uganda . Consenting eligible woman treat BV , randomise either NET-EN plus condom condom . Women currently use DMPA enrol observational comparison arm . All participant interview examine ; sample vaginal microbiota , sexually transmitted infection , inflammatory marker obtain . Women follow 1 week , 1 , 2 , 3 , 4 6 month . The primary outcome difference vaginal microbiota cluster , time recurrent BV , inflammatory marker . Qualitative research carry assess acceptability , adherence , NET-EN .</detailed_description>
	<mesh_term>Vaginal Diseases</mesh_term>
	<mesh_term>Vaginosis , Bacterial</mesh_term>
	<mesh_term>Norethindrone</mesh_term>
	<mesh_term>Norethindrone acetate</mesh_term>
	<mesh_term>Norethindrone enanthate</mesh_term>
	<criteria>BV positive Nugent score HIV negative Capable provide write informed consent Currently pregnant use reliable contraception ( e.g . injectables , intrauterine device , implant , oral contraceptive pill ) Desiring pregnancy next year History tubal ligation hysterectomy Contraindication progestinonly contraceptives Unable comprehend consent material language barrier psychological difficulty</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>35 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>